N-Acetylcysteine overcomes epalrestat-mediated increase of toxic 4-hydroxy-2-nonenal and potentiates the anti-arthritic effect of epalrestat in AIA model.

Abstract

Epalrestat, an aldose reductase inhibitor (ARI), has been clinically adopted in treating diabetic neuropathy in China and Japan. Apart from the involvement in diabetic complications, AR has been implicated in inflammation. Here, we seek to investigate the feasibility of clinically approved ARI, epalrestat, for the treatment of rheumatoid arthritis (RA). The mRNA level of AR was markedly upregulated in the peripheral blood mononuclear cells (PBMCs) of RA patients when compared to those of healthy donors. Besides, the disease activity of RA patients is positively correlated with AR expression. Epalrestat significantly suppressed lipopolysaccharide (LPS) induced TNF-α, IL-1β, and IL-6 in the human RA fibroblast-like synoviocytes (RAFLSs). Unexpectedly, epalrestat treatment alone markedly exaggerated the disease severity in adjuvant induced arthritic (AIA) rats with elevated Th17 cell proportion and increased inflammatory markers, probably resulting from the increased levels of 4-hydroxy-2-nonenal (4-HNE) and malondialdehyde (MDA). Interestingly, the combined treatment of epalrestat with N-Acetylcysteine (NAC), an anti-oxidant, to AIA rats dramatically suppressed the production of 4-HNE, MDA and inflammatory cytokines, and significantly improved the arthritic condition. Taken together, the anti-arthritic effect of epalrestat was diminished or even overridden by the excessive accumulation of toxic 4-HNE or other reactive aldehydes in AIA rats due to AR inhibition. Co-treatment with NAC significantly reversed epalrestat-induced upregulation of 4-HNE level and potentiated the anti-arthritic effect of epalrestat, suggesting that the combined therapy of epalrestat with NAC may sever as a potential approach in treating RA. Importantly, it could be regarded as a safe intervention for RA patients who need epalrestat for the treatment of diabetic complications.

• Authors: Linna Wang, Baixiong Huang, Yaling Zeng, Jiujie Yang, Zhi Li, Jerome P L Ng, Xiongfei Xu, Lu Su, Xiaoyun Yun, Liqun Qu, Ruihong Chen, Weidan Luo, Yuping Wang, Chang Chen, Lijun Yang, Yuanqing Qu, Wei Zhang, Joyce Tsz Wai Chan, Xingxia Wang, Betty Yuen Kwan Law, Simon Wing Fai Mok, Sookja Kim Chung, Vincent Kam Wai Wong
• Journal: International journal of biological sciences (Int J Biol Sci) Vol. 19 Issue 13 Pg. 4082-4102 ( 2023) ISSN: 1449-2288 [Electronic] Australia
• PMID: 37705749 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © The author(s).

Chemical References

• Acetylcysteine
• 4-hydroxy-2-nonenal
• epalrestat
• Aldehydes

Topics

• Humans
• Animals
• Rats
• Acetylcysteine (therapeutic use)
• Leukocytes, Mononuclear
• Aldehydes
• Arthritis, Rheumatoid (drug therapy)